These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6907062)

  • 1. Renal hemodynamic changes during long-term antihypertensive therapy.
    Warren SE; O'Connor DT; Cohen IM; Mitas JA
    Clin Pharmacol Ther; 1981 Mar; 29(3):310-7. PubMed ID: 6907062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal perfusion changes during treatment of essential hypertension: prazosin versus propranolol.
    O'Connor DT; Preston RA; Sasso EH
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S38-42. PubMed ID: 94638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in renal arterial flow during the treatment of essential arterial hypertension; prazosin in comparison with propranolol].
    O'Connor DT; Preston RA; Sasso EH
    Cardiology; 1980; 66 Suppl 2():69-73. PubMed ID: 7285032
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of guancydine on systemic and renal hemodynamics in arterial hypertension.
    Villarreal H; Arcila H; Ramirez MA
    Clin Pharmacol Ther; 1971; 12(5):838-42. PubMed ID: 4936149
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal effects of guanabenz: a new antihypertensive.
    Bosanac P; Dubb J; Walker B; Goldberg M; Agus ZS
    J Clin Pharmacol; 1976; 16(11-12):631-6. PubMed ID: 993358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enalapril in essential hypertension.
    Herrera-Acosta J; Pérez-Grovas H; Fernández M; Arriaga J
    Drugs; 1985; 30 Suppl 1():35-46. PubMed ID: 2994986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertensive nephropathy: is a more physiologic approach to blood pressure control an important concern for the preservation of renal function?
    Weir MR
    Am J Med; 1992 Aug; 93(2A):27S-37S. PubMed ID: 1519633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind controlled study of rilmenidine versus hydrochlorothiazide in mild hypertension: clinical and renal haemodynamic evaluation.
    Licata G; Scaglione R; Guillet C; Capuana G; Parrinello G; Indovina A; Lipari R; Mazzola G; Merlino G
    J Hum Hypertens; 1993 Apr; 7(2):153-7. PubMed ID: 8510088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term versus short-term effects of hydrochlorothiazide on renal haemodynamics in essential hypertension.
    Van Brummelen P; Woerlee M; Schalekamp MA
    Clin Sci (Lond); 1979 May; 56(5):463-9. PubMed ID: 477231
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary kallikrein activity and renal vascular resistance in the antihypertensive response to thiazide diuretics.
    O'Connor DT; Preston RA; Mitas JA; Frigon RP; Stone RA
    Hypertension; 1981; 3(1):139-47. PubMed ID: 6907170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of clonidine therapy on exchangeable sodium and renal hemodynamics in essential hypertension.
    Todesco S; Huber W; Romagnoli GF; Gambari PF; Guardini R; Borsatti A
    Arzneimittelforschung; 1974 Mar; 24(3):348-51. PubMed ID: 4407413
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative effects of antihypertensive therapy with guanabenz and propranolol on renal vascular resistance and left ventricular mass.
    Mosley C; O'Connor DT; Taylor A; Slutsky RA; Cervenka J
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S757-61. PubMed ID: 6084120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the effects of ST 600 and clonidine.
    Kho TL; Schalekamp MA; Zaal GA; Wester A; Birkenhäger WH
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):162-9. PubMed ID: 1190909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic renal effects of guanfacine in essential and renal hypertension.
    Roeckel A; Heidland A
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):141S-149S. PubMed ID: 6994769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal effects of nitrendipine.
    Ruilope LM
    J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S10-3. PubMed ID: 1725795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Enalapril in the treatment of essential arterial hypertension].
    Pérez-Grovas H; Fernández M; Arriaga J; Herrera-Acosta J
    Arch Inst Cardiol Mex; 1986; 56(5):379-90. PubMed ID: 3026264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal hemodynamic effects of tertatolol in essential hypertension.
    Paillard F; Lantz B; Leviel F; Ardaillou R
    Am J Nephrol; 1986; 6 Suppl 2():40-4. PubMed ID: 2879472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?
    Verdalles U; García de Vinuesa S; Goicoechea M; Macías N; Santos A; Perez de Jose A; Verde E; Yuste C; Luño J
    Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical evaluation of prazosin, a new antihypertensive agent.
    Pitts NE
    Postgrad Med; 1975 Nov; Spec No():117-27. PubMed ID: 1105484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.